Browse

Decision-making about new products is crucial for the growth and prosperity of any company, especially in the rapidly changing medical device market. In recent years the issue of evaluation of investment effectiveness into medical devices has been intensively solved both at private and national level. The most common methods can be divided into three groups: 1. strategic and financial valuation of projects (e.g., NPV, IRR, DCF), 2. weighting and scoring of products and product criteria (e.g., analytic hierarchy pr...